(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. Identification of an enhancer to drive lacZ expression in the
dorsal spinal cord. (A) Schematic representation of the genomic structure of
Mbh1 and Mbh1/lacZ transgenes. The orange boxes
indicate exons, and translation start site (ATG) is designated as nucleotide
number 1. The blue and green boxes represent lacZ and the
ß-globin promoter/lacZ construct (BGZA),
respectively. The 3' fragment was reversed in Tg6. The number of
transgenic (#TgM) and ß-gal+ (#expression) embryos are shown
in the table; athe two embryos expressed lacZ at low
levels in the midbrain. Lateral (B) and dorsal (C-E) views of representative
ß-gal+ embryos harboring Tg2 (B,C), Tg4 (D) and Tg5 (E).
Transverse sections of the embryos carrying Tg2 (F) and Tg4 (G). Arrowheads
indicate ß-gal+ ventral funiculi. (H) Transverse section of
the embryo carrying Tg4 was immunostained with antibodies against Math1 (red)
and ß-gal (green). Scale bars: in B, 1 mm for B-E; in F, 100 µm for
F,G; in H, 50 µm.